Percutaneous revascularization strategies in small-vessel disease

E Puymirat1, E Barbato2

  • 1Cardiovascular center Aalst, OLV hospital, Aalst, Belgium; Department of cardiology, hôpital européen Georges-Pompidou, Assistance publique-Hôpitaux de Paris, 20, rue Leblanc, 75015 Paris, France; Université Paris Descartes, 75005 Paris, France; Inserm U970, Paris Cardiovascular Research Center PARCC, 75015 Paris, France.

Annales De Cardiologie Et D'Angeiologie
|August 31, 2013
PubMed

Insights

Percutaneous coronary intervention (PCI) in small coronary vessels is challenging due to high risks. This review examines PCI strategies for small vessel coronary artery disease, addressing its clinical significance and treatment heterogeneity.

Area of Science:

  • Cardiology
  • Interventional Cardiology
  • Vascular Medicine

Background:

  • Percutaneous coronary intervention (PCI) in small coronary vessels poses significant challenges.
  • High risks of stent-restenosis and adverse clinical events are associated with small vessel PCI.
  • The clinical significance of small vessel stenoses is debated due to small myocardial territories supplied.

Purpose of the Study:

  • To review percutaneous coronary revascularization strategies in patients with small vessel coronary artery disease.
  • To address the heterogeneity in definitions and PCI strategies for small vessel disease.
  • To explore the clinical relevance and management of stenoses in small coronary arteries.

Main Methods:

  • Literature review focusing on percutaneous coronary intervention in small coronary vessels.
  • Analysis of studies defining small vessel disease and associated PCI strategies.
  • Synthesis of current evidence on myocardial revascularization for small vessel coronary artery disease.

Main Results:

  • Small vessel PCI is associated with higher rates of stent-restenosis and adverse clinical events.
  • Heterogeneity exists in the definition of small vessel disease and PCI approaches across studies.
  • The clinical impact of treating small vessel stenoses remains a subject of ongoing research and debate.

Conclusions:

  • Percutaneous coronary intervention for small coronary vessels presents unique challenges and risks.
  • Standardized definitions and optimized PCI strategies are needed for effective management.
  • Further research is essential to clarify the clinical significance and optimal revascularization approach for small vessel coronary artery disease.

Related Concept Videos

Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Peripheral Artery Disease IV: Nursing Management01:26

Peripheral Artery Disease IV: Nursing Management

The nursing management of a patient with peripheral artery disease (PAD) begins with a thorough assessment of the patient’s health history and clinical manifestations.AssessmentHealth History: Evaluate the patient’s history of hypertension, hyperlipidemia, family history of cardiovascular issues, and lifestyle factors such as dietary patterns, smoking, and physical activity.Physical Examination:Assess the affected extremity for decreased or absent peripheral pulses, temperature changes,...